• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BD (SUZHOU) BD PEGASUS YEL 24GAX0.75IN QSYTE-CAPY NOPVC; INTRAVASCULAR CATHETER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BD (SUZHOU) BD PEGASUS YEL 24GAX0.75IN QSYTE-CAPY NOPVC; INTRAVASCULAR CATHETER Back to Search Results
Catalog Number 383718
Device Problem Packaging Problem (3007)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 12/20/2023
Event Type  malfunction  
Manufacturer Narrative
H.3.A device evaluation and/or device history review is anticipated but is not complete.Upon completion, a supplemental report will be filed.
 
Event Description
It was reported that bd pegasus yel 24gax0.75in qsyte-capy nopvc had packaging damage.The following information was provided by the initial reporter, translated from chinese to english: used in the department for intravenous infusion, drug administration and taking blood samples, the packaging was found to be broken and not in compliance with aseptic operation at the time of use, and the hospital's storekeeper was contacted to replace it with a new product.
 
Manufacturer Narrative
Dhr/bhr review: the batch number of the complained product is 3170893, is 24g and product code is 383718, produced on 2023/07, with a total of (b)(4) pieces in this batch; inspection process inspection and delivery inspection report, the test results meet the product standards, no abnormality.Check the production records for this batch of products that there are no nonconformities, deviations or rework activities in the process of this batch of products.The customer did not return any samples or photos ,cannot confirm the specific defect status.Take the retained samples 28pcs do the packaging appearance inspection, and no abnormalities were found.The inspection report is attached as attachment 1.The history of customer complaints for the same batch of products has been reviewed, and no complaints of the same defects have been found.In summary, the customer did not return any samples or photos, can not confirm the specific defect of the product, the root cause of the complaint defect cannot be confirmed, and the factory will continue to pay attention to and monitor the trend of the defect complaint.
 
Event Description
No additional information provided.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BD PEGASUS YEL 24GAX0.75IN QSYTE-CAPY NOPVC
Type of Device
INTRAVASCULAR CATHETER
Manufacturer (Section D)
BD (SUZHOU)
no. 5 baiyu road
suzhou industrial park
suzhou
Manufacturer (Section G)
BD (SUZHOU)
no. 5 baiyu road
suzhou industrial park
suzhou
Manufacturer Contact
helen cox (mdr)
75 north fairway drive
vernon hills, IL 60061
8473935694
MDR Report Key18530263
MDR Text Key333485665
Report Number3014704491-2024-00011
Device Sequence Number1
Product Code FOZ
UDI-Device Identifier382903837182
UDI-Public(01)382903837182
Combination Product (y/n)N
Reporter Country CodeCH
PMA/PMN Number
NA
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,Foreign
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date 03/11/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Other
Device Catalogue Number383718
Device Lot Number3170893
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 12/26/2023
Initial Date FDA Received01/17/2024
Supplement Dates Manufacturer Received03/11/2024
Supplement Dates FDA Received03/19/2024
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured06/19/2023
Is the Device Single Use? Yes
Type of Device Usage Initial
Patient Sequence Number1
-
-